Donor lymphocyte infusion administrations after allogeneic stem cell transplantations in pediatrics: A single center experience

dc.contributor.authorAydoğdu, Selime
dc.contributor.authorMergen, Azize
dc.contributor.authorAksoy, Başak
dc.contributor.authorAkbay, Hazal S.
dc.contributor.authorCipe, Funda
dc.contributor.authorDikme, Gürcan
dc.contributor.authorBozkurt, Ceyhun
dc.contributor.authorFışgın, Tunç
dc.date.accessioned2021-05-15T11:34:29Z
dc.date.available2021-05-15T11:34:29Z
dc.date.issued2019
dc.departmentTıp Fakültesi, Dahili Tıp Bilimlerien_US
dc.description45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT) -- MAR 24-27, 2019 -- Frankfurt, GERMANY
dc.description.abstractAllogeneic stem cell transplantation (allo-SCT) is considered the cornerstone in the treatment of several malignant and not malignant hematological diseases. However, relapse of hematological disease after allo-SCT is considered the most challenging point in the field. The risk can be reduced through optimal patients, donor and disease selection before allo-SCT, but harnessing donor immune system is an appealing way to treat or avoid disease relapse. Donor lymphocyte infusion (DLI) is a simple and effective therapy after allo-SCT. In this paper, the efficacy of DLI will be analyzed in different hematological diseases, focusing also on their therapeutic or pre-emptive use.en_US
dc.description.sponsorshipEuropean Soc Blood & Marrow Transplantaten_US
dc.identifier.endpage196en_US
dc.identifier.issn0268-3369
dc.identifier.issn1476-5365
dc.identifier.startpage196en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12939/330
dc.identifier.volume54en_US
dc.identifier.wosWOS:000487707800216
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.institutionauthorFışgın, Tunç
dc.institutionauthorAkbay, Hazal S.
dc.language.isoen
dc.publisherNature Publishing Groupen_US
dc.relation.ispartofBone Marrow Transplantation
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectDonorsen_US
dc.subjectAllogeneic Stem Cellen_US
dc.subjectPediatricsen_US
dc.titleDonor lymphocyte infusion administrations after allogeneic stem cell transplantations in pediatrics: A single center experience
dc.typeConference Object

Dosyalar